Cerebain Biotech Announces Engagement Of Consultant For Representation In China
1/21/2014 9:07:36 AM
DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced today that it has engaged John Ballard to represent the Company in The People’s Republic of China for the purpose of Clinical Testing of the Company’s Medical Device for the treatment of Alzheimer’s Disease utilizing the Omentum. The Consultant will serve as the intermediary in China to determine and finalize any required local approvals and establish essential partnerships with Doctors and Medical Facilities necessary for this testing once the Company’s prototype is completed. The medical device is being developed by Cerebain Biotech Corp as a potential new approach for the treatment for patients suffering from Alzheimer’s and Dementia.
Help employers find you! Check out all the jobs and post your resume.
comments powered by